Tremfya rescues J&J’s immunology sales to fuel strong Q3
Johnson & Johnson (J&J) leaned on strong demand for anti-inflammatory drug Tremfya (guselkumab) to offset steep erosion in other areas…
13 Oct 2026
Abram snags $8.3M US DoD contract to advance blood coagulation diagnostic
Abram Scientific has been awarded a Defense Advanced Research Projects Agency (DARPA) contract worth up to $8.3m, setting the company up with funds to advance its blood coagulation testing platform.…
13 Oct 2026
Steris outlays $2.1bn to acquire Xodus Medical
Steris has penned a deal to acquire surgical safety solutions developer, Xodus Medical, for $2.1bn – adding a range of speciality healthcare consumable products to its portfolio as it sees…
13 Oct 2026
E2 wins FDA clearances for integrated Hēlo thrombectomy platform
Endovascular Engineering (E2) has secured a dual US Food and Drug Administration (FDA) clearance for Hēlo Return’s use alongside its venous thromboembolism (VTE) catheter. E2 asserted that Hēlo Return ‘completes’…
13 Oct 2026
Hiossen and GuidedSMILE collaborate on dental implant workflows
GuidedSMILE and Hiossen Implants have announced a strategic partnership to expand dental professionals' access to guided full-arch implant procedures across North America. The commercial arrangement links GuidedSMILE’s patented stackable surgical…
13 Oct 2026
First patient treated in Spiro’s PULSAR asthma trial
Spiro Medical has treated the first patient in its PULSAR feasibility study evaluating neuromodulation for severe, uncontrolled asthma. The clinical-stage medical device company is conducting the clinical investigation under an…
12 Oct 2026
Stryker invests $400m into CMR Surgical; secures future buyout option
Stryker is furthering its presence in the surgical robotics market via a strategic pair-up with CMR Surgical that will see the orthopaedics giant inject $400m to support US commercialisation efforts…